Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans

Imaging of dopamine D2/3 agonist binding in cocaine dependence: A [11C]NPA positron emission tomography study

(2011) Rajesh Narendran et al.   SYNAPSE

Dysfunctional Brain Networks and Genetic Risk for Schizophrenia: Specific Neurotransmitter Systems

(2010) Jussi Hirvonen et al.   CNS Neuroscience & Therapeutics

D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: A PET study in a receptor internalization-deficient mouse model

(2010) Mette Skinbjerg et al.   NEUROIMAGE

Co-operativity in agonist binding at the D2dopamine receptor: evidence from agonist dissociation kinetics

(2009) Elodie Kara et al.   JOURNAL OF NEUROCHEMISTRY

Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2receptor in vitro

(2009) Patrick N. McCormick et al.   SYNAPSE

Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2and D3dopamine receptors

(2009) Mette Skinbjerg et al.   SYNAPSE

The Dopamine D2 Receptors in High-Affinity State and D3 Receptors in Schizophrenia: A Clinical [11C]-(+)-PHNO PET Study

(2008) Ariel Graff-Guerrero et al.   NEUROPSYCHOPHARMACOLOGY

Dopamine D2 receptor radiotracers [11C](+)-PHNO and [3H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo

(2007) Patrick N. McCormick et al.   NUCLEAR MEDICINE AND BIOLOGY